FIELD: medicine; pharmacology.
SUBSTANCE: invention is medicinal agent containing rybafutin, copolymer of lactic and glycolic acids (PLGA 50/50), D-mannitol, polysorbate 80 and dimethyl sulfoxide, as well as related method of production implying that mixed rybafutin, PLGA 50/50, D- mannitol, polysorbate 80 are heated at 50÷60°C and stirred until solid phase is completely dissolved, then cooled to room temperature, added with water at ratio 1 : 20 to 1 : 10 followed with nanoparticles˜200÷400 nm suspension produced as a result.
EFFECT: reduced toxicity of active substance accompanying maintained antimicrobic action and simplified production of end formulation.
3 cl, 4 ex, 4 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMICROBIAL MEDICINAL AGENT, METHOD OF PRODUCTION OF DIRECTIONAL MEDICINAL AGENT CONTAINIG NANOPARTICLES | 2007 |
|
RU2327459C1 |
| D-CYCLOSERINE-BASE DRUG, NANOPARTICLES-CONTAINING PREPARATION OF PROLONGED EFFECT, METHOD FOR ITS PREPARING | 2007 |
|
RU2318513C1 |
| AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
| DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
| RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
| ANTIBACTERIAL AGENT FOR TREATMENT OF INTRACELLULAR INFECTION | 2006 |
|
RU2308970C1 |
| D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
| ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
| METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
| GLYCINE-BASED PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION AND METHOD OF ITS OBTAINING | 2011 |
|
RU2457835C1 |
